» Authors » Francoise Roudot-Thoraval

Francoise Roudot-Thoraval

Explore the profile of Francoise Roudot-Thoraval including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 143
Citations 4224
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Roulot D, Layese R, Brichler S, Ganne N, Asselah T, Zoulim F, et al.
Clin Gastroenterol Hepatol . 2024 Oct; PMID: 39461464
Background & Aims: The specific causative role of hepatitis delta virus (HDV) infection in the development of hepatocellular carcinoma (HCC) remains debated and was not specifically demonstrated in patients with...
2.
Roulot D, Brichler S, Layese R, DAlteroche L, Ganne-Carrie N, Stern C, et al.
Clin Gastroenterol Hepatol . 2024 Aug; PMID: 39209196
Background & Aims: Liver biopsy remains the gold standard for fibrosis staging in patients with chronic hepatitis delta (CHD). Here, we comparatively evaluated the performance of transient elastography (TE) and...
3.
Brichler S, Trimoulet P, Roque-Afonso A, Izopet J, Thibault V, Roudot-Thoraval F, et al.
Liver Int . 2024 Aug; 44(10):2858-2865. PMID: 39115174
Background And Aims: Chronic hepatitis D infection is the most severe form of viral hepatitis and can rapidly progress to cirrhosis or hepatocellular carcinoma. Despite recommendations for systematic screening of...
4.
Duracinsky M, Yaya I, Yombo-Kokule L, Bessonneau P, Thonon F, Rousset-Torrente O, et al.
BMJ Open . 2024 Jun; 14(6):e075315. PMID: 38839381
Objectives: Migrants from high HIV, hepatitis B virus (HBV) or hepatitis C virus (HCV) endemicity regions have a great burden of these infections and related diseases in the host countries....
5.
Sidali S, Borie R, Sicre de Fontbrune F, El Husseini K, Rautou P, Lainey E, et al.
Hepatology . 2023 Nov; 79(6):1365-1380. PMID: 37934624
Background And Aim: Germline mutations of telomere-related genes (TRG) induce multiorgan dysfunction, and liver-specific manifestations have not been clearly outlined. We aimed to describe TRG mutations-associated liver diseases. Approach And...
6.
Brustia R, Bouattour M, Allaire M, Lequoy M, Hollande C, Regnault H, et al.
Ann Hepatol . 2023 Jul; 28(6):101141. PMID: 37468096
Introduction And Objectives: The lockdown policy introduced in 2020 to minimize the spread of the COVID-19 pandemic, significantly affected the management and care of patients affected by hepatocellular carcinoma (HCC)....
7.
Chevaliez S, Roudot-Thoraval F, Brouard C, Gordien E, Zoulim F, Brichler S, et al.
JHEP Rep . 2022 Oct; 4(12):100593. PMID: 36313185
Background & Aims: Among people living with HBV, only a subset of individuals with chronic hepatitis is in need of treatment, and this proportion varies according to the population, region,...
8.
Nguyen-Khac V, Brustia R, Rhaiem R, Regnault H, Sessa A, Mule S, et al.
Ann Hepatol . 2022 Jul; 27(6):100739. PMID: 35781089
Introduction And Objectives: Liver resection is the only curative therapeutic option for large hepatocellular carcinoma (> 5 cm), but survival is worse than in smaller tumours, mostly due to the...
9.
Pol S, Fouad F, Lemaitre M, Rodriguez I, Lada O, Rabiega P, et al.
Lancet Reg Health Eur . 2021 Dec; 13:100281. PMID: 34950924
Background: Direct antiviral agents (DAAs) became available in France in 2014 for the treatment of chronic hepatitis C (CHC) in patients with severe fibrosis (prioritized access); in 2017, DAAs became...
10.
Chevaliez S, Roudot-Thoraval F, Hezode C, Pawlotsky J, Njouom R
Future Microbiol . 2021 Jul; 16:713-719. PMID: 34227402
HCV diagnosis will become the bottleneck in eliminating hepatitis C. Simple, accurate and cost-effective testing strategies are urgently needed to improve hepatitis C screening and diagnosis. Performance of seven rapid...